clinical trials
Welcome to the 'clinical trials' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'clinical trials'.
Are you an expert about 'clinical trials'? Do you want to be the Technorati authority on 'clinical trials'? You can write a description that will appear right here:
Join Blogcritics!
Original Technorati articles tagged “clinical trials”
-
FDA Rescinds Approval of Avastin for Breast Cancer Treatment
The Food and Drug Administration has revoked its approval of the drug Avastin the treatment of metastatic breast cancer.by jenna3967 / on Nov 18, 2011
Latest blogosphere posts tagged “clinical trials”
-
ResearchMoz: Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
PR News Wire —
Authority: 836
ALBANY, New York, February 2, 2012 /PRNewswire/ --New Report Added in ResearchMoz Reports Database Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017GlobalData, the industry analysis specialist, has released its new report, Postmenopausal...2 hours ago -
Clinical Trials in CIS Countries 2012
PR News Wire —
Authority: 836
NEW YORK, Feb. 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Clinical trials in CIS countries 2012...2 hours ago -
Shire and Sangamo Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases
PR News Wire —
Authority: 836
DUBLIN and RICHMOND, Calif., Feb. 1, 2012 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, and Sangamo BioSciences, Inc. (NASDAQ: SGMO), a leader in genome-editing technology, announced today that they have entered into a...23 hours ago -
PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs
PR News Wire —
Authority: 836
BOSTON and SEOUL, Korea, Feb. 1, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, announced today that it has entered into an agreement with ASAN Medical Center (AMC), based in Seoul, Korea. The alliance...1 day ago -
Forschende Pharmaindustrie sagt 14 Mrd. Behandlungen zur Ausrottung von neun vernachlässigten Tropenkrankheiten zu
PR News Wire —
Authority: 836
GENF, Schweiz, February 1, 2012 /PRNewswire/ --Spenden konzentrieren sich auf die Umsetzung neuer WHO-Ziele für maximale Wirksamkeit gegen vernachlässigte Tropenkrankheiten (Neglected Tropical Diseases/NTD)Basis für die Kampagne ist die langjährige Erfahrung der...1 day ago -
Intelsius Launches New Patient Safety Products
PR News Wire —
Authority: 836
BASEL, Switzerland, Jan. 31, 2012 /PRNewswire/ -- Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions, announces the launch of its new Thermotrek™ range of products.(Photo:...2 days ago -
Inovio Pharmaceuticals Moves Closer to "Universal" Influenza Vaccine by Demonstrating Protective Immune Responses Against Multiple H3N2 and Type B Strains in Animal Studies
PR News Wire —
Authority: 836
BLUE BELL, Pa., Jan. 31, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO) announced today that its synthetic vaccines for influenza Type A H3N2 and Type B achieved protective antibody responses in immunized animals against multiple unmatched strains. Inovio...2 days ago -
New Clinical Study Finds Use of Tissuemeds Sealant Film TissuePatchDural "Encouraging" in Prevention of CSF Leaks
PR News Wire —
Authority: 836
LEEDS, England, January 31, 2012 /PRNewswire/ --UK surgical sealant film company Tissuemed Ltd. has announced the publication of a new clinical paper in World Neurosurgery relating to its self-adhesive dural sealant film products.Authored by Dr Paolo Ferroli, Professor Giovanni Broggi...2 days ago -
La película sellante de Tissuemed, TissuePatchDural es "alentadora" en la prevención de derrames CSF
PR News Wire —
Authority: 836
LEEDS, Inglaterra, January 31, 2012 /PRNewswire/ -- Un nuevo estudio clínico encuentra el uso de la película sellante de Tissuemed, TissuePatchDural como "alentador" en la prevención de derrames CSFLa compañía de película selladora...2 days ago -
Prévention des fuites de LCR : résultats "encourageants" du film détanchéité TissuePatchDural de Tissuemed selon une nouvelle étude clinique
PR News Wire —
Authority: 836
LEEDS, Angleterre, January 31, 2012 /PRNewswire/ --Le fabricant britannique de films détanchéité bio-compatibles Tissuemed Ltd. vient dannoncer la publication dune nouvelle étude clinique dans World Neurosurgery sur ses films étanches auto-adhésifs...2 days ago -
Neue klinische Studie beschreibt den Einsatz von Tissumeds Dicht- und Barrierefolie TissuePatchDural zur Dura-Versiegelung als "vielversprechend"
PR News Wire —
Authority: 836
LEEDS, England, January 31, 2012 /PRNewswire/ --Der im Vereinigten Königreich angesiedelte Hersteller von chirurgischen Dicht- und Barrierefolien Tissuemed Ltd. gab die Veröffentlichung einer neuen klinischen Studie über seine selbstklebenden Barrierefolien zur...2 days ago -
VGX-100 Identified as Potential New Therapy for Improving Corneal Graft Survival
PR News Wire —
Authority: 836
MELBOURNE, Australia, Jan. 30, 2012 /PRNewswire/ -- Circadian Technologies Limited (ASX: CIR, OTCQX: CKDXY) announced today the publication of data in the scientific journal, Investigative Ophthalmology & Visual Science (IOVS), showing that VEGF-C expression...2 days ago -
Research-Based Pharmaceutical Industry Pledges 14 Billion Treatments to Help End Nine Neglected Tropical Diseases
PR News Wire —
Authority: 836
GENEVA, January 30, 2012 /PRNewswire/ --Donations focused on meeting new WHO targets for maximum impact against NTDs Builds on industrys long-standing record of innovating treatments for neglected tropical diseasesToday the research-based pharmaceutical industry announced...3 days ago -
La industria farmacéutica promete 14.000 millones de tratamientos para nueve enfermedades tropicales
PR News Wire —
Authority: 836
GINEBRA, January 30, 2012 /PRNewswire/ --- La industria farmacéutica basada en la investigación promete 14.000 millones de tratamientos para ayudar a terminar con nueve enfermedades tropicales desatendidasDonaciones centradas en alcanzar nuevos objetivos de la OMS para un...3 days ago -
Lindustrie pharmaceutique basée sur la recherche promet un don de 14 milliards de traitements pour aider à éradiquer neuf maladies tropicales négligées
PR News Wire —
Authority: 836
GENÈVE, January 30, 2012 /PRNewswire/ -- Dons concentrés sur latteinte des nouvelles cibles de lOMS pour un impact maximal contre les MTN Renforcement de lhistorique de longue date de lindustrie en matière de traitements novateurs contre les maladies...3 days ago -
Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clinical Trials
PR News Wire —
Authority: 836
Canadian centre of excellence partners with US-based Molecular Insight Pharmaceuticals to manufacture a new radiopharmaceutical for clinical trials that will evaluate the potential to deliver targeted radiotherapy directly to metastatic prostate cancer.HAMILTON, ON, and CAMBRIDGE,...3 days ago -
Adventures in defending science-based medicine in cancer journals: Energy chelation
Science-Based Medicine —
Authority: 500
My co-bloggers and I have spent considerable time and effort over the last four years writing posts for this blog (and I for my not-so-super-secret other blog) bemoaning the infiltration of quackademic medicine into what once were bastions of evidence- and science-based medicine. We’ve discussed at considerable ...3 days ago -
New Clinical Trial Guidelines For Migraine
Relief headache and treatment —
Authority: 102
Experts from the International Headache Society (IHS) wish developed new recommendations for conduct of piercing and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is things being so available in the IHS journal Cephalalgia, that is published by SAGE.The commencing ...1 week ago -
LEO Pharma Announces That Picato® (ingenol mebutate) gel has Been Approved by US FDA for Once-Daily, 2 or 3 day Treatment of Actinic Keratoses
PR News Wire —
Authority: 836
COPENHAGEN, Denmark, January 26, 2012 /PRNewswire/ --LEO Pharma today announced that Picato® (ingenol mebutate) gel (0.015%, 0.05%) has been approved by the US Food and Drug Administration (FDA) as a treatment for actinic keratoses (AK) on the face, scalp, trunk and extremities....1 week ago -
Cord Blood America Reports that Umbilical Cord Blood Stem Cells Are Now Being Used in Experimental Effort to Treat Type 1 Diabetes
PR News Wire —
Authority: 836
LAS VEGAS, Jan. 25, 2012 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and...1 week ago


Follow Technorati